Free Trial
→ Buffett’s Next Move Could Shock Wall Street (From Golden Portfolio) (Ad)
NASDAQ:GCTK

GlucoTrack 11/14/2023 Earnings Report

GlucoTrack logo
$0.13 0.00 (-2.69%)
As of 12:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
ProfileEarnings History

GlucoTrack EPS Results

Actual EPS
-$10.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Date
11/14/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GlucoTrack Earnings Headlines

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
May 28 at 8:30 AM | globenewswire.com
GCTK stock plunges to 52-week low, touches $0.13
May 23, 2025 | uk.investing.com
Social Security Could Change Forever — Here's What I Know
When we say the way income could be calculated for Social Security is about to change forever — we don't make that claim lightly. These institutions pay us top dollar because we track exactly how big federal changes like this could send ripples through the stock market. And right now, we are sounding the alarm.
May 30, 2025 | Altimetry (Ad)
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
May 20, 2025 | globenewswire.com
GlucoTrack, Inc.: Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 15, 2025 | finanznachrichten.de
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 14, 2025 | globenewswire.com
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles